Read More
20% Returns in 1 Month: This Piramal Group Pharma Stock Reports 17% Revenue...
Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...
Articles tagged with "CDMO Business"
Read More
US Biosecure Act, China Plus One, and Trump’s Tariff War: CDMOs Are Hot Top...
Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However...